Milestone® Pharmaceuticals to Present at the TD Cowen 46th Annual Health Care Conference Feb 26, 2026 08:00AM
TD Cowen Upgrades Milestone Pharmaceuticals (MIST) to Buy Dec 15, 2025 10:03AM
Milestone Pharmaceuticals prices $52.5 million public offering Jul 11, 2025 09:32AM
Milestone Pharmaceuticals Announces Pricing of $52.5 Million Public Offering of Common Shares, Pre-Funded Warrants, Series A Common Warrants and Series B Common Warrants Jul 11, 2025 09:30AM
Milestone Pharmaceuticals announces public offering of shares and warrants Jul 11, 2025 06:02AM


Jul 11, 2025 06:01AM Milestone Pharmaceuticals Announces Proposed Public Offering
Apr 1, 2025 06:13AM TD Cowen Downgrades Milestone Pharmaceuticals (MIST) to Hold
Feb 27, 2025 08:00AM Milestone® Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference
Oct 21, 2024 08:42AM TD Cowen Reiterates Buy Rating on Milestone Pharmaceuticals (MIST)
Sep 9, 2024 08:45AM TD Cowen Reiterates Buy Rating on Milestone Pharmaceuticals (MIST)
Feb 29, 2024 04:01PM Milestone® Pharmaceuticals to Participate in a Corporate Panel Discussion at TD Cowen 44th Annual Health Care Conference
Mar 28, 2023 07:04AM Milestone Pharmaceuticals (MIST) Announces $125M Financing with RTW Investments
Mar 28, 2023 07:00AM Milestone Pharmaceuticals Announces $125 Million Strategic Financing with RTW Investments to Support the Advancement of Etripamil for PSVT
Feb 28, 2023 07:00AM Milestone Pharmaceuticals to Present at Upcoming Investor Conferences
Oct 17, 2022 09:48AM Milestone Pharmaceuticals (MIST) PT Raised to $17 at Cowen Following Data
Mar 1, 2022 07:00AM Milestone Pharmaceuticals to Present at Upcoming Investor Conferences
Feb 25, 2021 07:00AM Milestone Pharmaceuticals to Present at Upcoming Investor Conferences
Jul 23, 2020 03:43PM Milestone Pharmaceuticals (MIST) PT Doubled to $12 at Cowen
Jul 16, 2019 07:32AM Pappas Capital Expands Leadership Team With Appointments Of Kyle Rasbach To Managing Partner And Matthew Boyer To Chief Financial Officer
Jun 3, 2019 05:57AM Cowen Starts Milestone Pharmaceuticals (MIST) at Outperform
May 14, 2019 06:40PM Milestone Pharmaceuticals Announces Full Exercise of Underwriters' Option to Purchase Additional Shares in Its Initial Public Offering
May 13, 2019 04:05PM Milestone Pharmaceuticals Announces Closing of Initial Public Offering
May 9, 2019 10:02AM Milestone Pharmaceuticals (MIST) IPO Opens 4% Higher
May 9, 2019 06:51AM Milestone Pharmaceuticals Inc. (MIST) Prices Upsized 5.5M Share IPO at $15/Sh
May 8, 2019 11:02PM Milestone Pharmaceuticals Announces Pricing of Upsized Initial Public Offering